Adeona Pharmaceuticals' Oral dnaJP1 Phase II Clinical Findings Presented At the American College of Rheumatology Annual Meeting
October 28, 2008 08:59 ET
|
Adeona Pharmaceuticals, Inc.
ANN ARBOR, Mich., Oct. 28, 2008 (GLOBE NEWSWIRE) -- Adeona Pharmaceuticals, Inc. (AMEX:AEN), a specialty pharmaceutical company developing innovative late-stage drug candidates for the treatment of...
Lazare Kaplan International Inc. to Webcast 2008 Annual Meeting of Shareholders
October 28, 2008 08:05 ET
|
Lazare Kaplan International
NEW YORK, Oct. 28, 2008 (GLOBE NEWSWIRE) -- Lazare Kaplan International Inc. (AMEX:LKI), a manufacturer and marketer of diamonds and jewelry products, will conduct its annual meeting of shareholders...
Cytomedix to Present At Rodman & Renshaw 10th Annual Healthcare Conference On Wednesday, Nov. 12, 2008
October 20, 2008 08:00 ET
|
Cytomedix, Inc.
ROCKVILLE, Md., Oct. 20, 2008 (GLOBE NEWSWIRE) -- Cytomedix, Inc. (AMEX:GTF) today announced that Chief Executive Officer Martin Rosendale will present an overview of the Company at the Rodman &...
Pipex Pharmaceuticals, Inc. Completes Corporate Name Change to Adeona Pharmaceuticals and Receives New Ticker Symbol
October 16, 2008 08:45 ET
|
Adeona Pharmaceuticals, Inc.
ANN ARBOR, Mich., Oct. 16, 2008 (GLOBE NEWSWIRE) -- Pipex Pharmaceuticals, Inc. (the "Company" or "Pipex") (AMEX:PP), a pharmaceutical company developing innovative late-stage oral drug candidates for...
Lazare Kaplan International Inc. Announces First Quarter Fiscal 2009 Results
October 14, 2008 16:10 ET
|
Lazare Kaplan International
NEW YORK, Oct. 14, 2008 (GLOBE NEWSWIRE) -- Lazare Kaplan International Inc. (AMEX:LKI) today announced financial results for the first fiscal quarter of fiscal 2009 ended August 31, 2008.
Net sales...
Pipex Pharmaceuticals' Oral Flupirtine Receives IRB Approval to Initiate Phase II Clinical Trial for Fibromyalgia
October 07, 2008 08:29 ET
|
Adeona Pharmaceuticals, Inc.
ANN ARBOR, Mich., Oct. 7, 2008 (GLOBE NEWSWIRE) -- Pipex Pharmaceuticals, Inc. (AMEX:PP), a specialty pharmaceutical company developing innovative late-stage drug candidates for the treatment of...
Cytomedix On Track With Sales and Marketing Efforts for AutoloGel System and Further Development of CT-112 Peptide, Annual Meeting Told
September 19, 2008 13:00 ET
|
Cytomedix, Inc.
ROCKVILLE, Md., Sept. 19, 2008 (GLOBE NEWSWIRE) -- Cytomedix, Inc. (AMEX:GTF) Chief Executive Officer Martin Rosendale told the Annual Meeting of Shareholders today that the Company is progressing...
Cytomedix Appoints Dr. Peter A. Clausen as Vice President of Business Development
September 10, 2008 07:30 ET
|
Cytomedix, Inc.
ROCKVILLE, Md., Sept. 10, 2008 (GLOBE NEWSWIRE) -- Cytomedix, Inc. (AMEX:GTF) today announced the appointment of Dr. Peter Anton Clausen, Ph.D., a seasoned biochemist with nearly 15 years experience...
Lazare Kaplan International Inc. Reports Fourth Quarter and Fiscal 2008 Year-End Results
September 08, 2008 16:05 ET
|
Lazare Kaplan International
NEW YORK, Sept. 8, 2008 (GLOBE NEWSWIRE) -- Lazare Kaplan International Inc. (AMEX:LKI) today announced financial results for the fourth fiscal quarter and year ended May 31, 2008.
For the fourth...
Lazare Kaplan International Inc. to Webcast Fiscal 2008 Fourth Quarter and Year-End Results
September 08, 2008 13:05 ET
|
Lazare Kaplan International
NEW YORK, Sept. 8, 2008 (GLOBE NEWSWIRE) -- Lazare Kaplan International Inc. (AMEX:LKI), a manufacturer and marketer of diamonds and jewelry products, intends to release its fiscal 2008 fourth quarter...